Brain-kidney crosstalk

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Nongnuch, Arkom ^a,b   Panorchan, Kwanpeemai ^b,c   Davenport, Andrew ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c BUMRUNGRAD INTERNATIONAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ALDOSTERONE; ANTIBIOTIC AGENT; BASE; BICARBONATE; CARBON DIOXIDE; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; ORGANIC ANION TRANSPORTER; PHOSPHATE; URIC ACID; VOLTAGE GATED CALCIUM CHANNEL;

ACUTE KIDNEY FAILURE; ALDOSTERONE BLOOD LEVEL; ANALGESIA; BICARBONATE BLOOD LEVEL; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN DEATH; BRAIN DISEASE; BRAIN FUNCTION; BRAIN INJURY; BRAIN THIRD VENTRICLE; BRAIN WATER; CALCIUM TRANSPORT; CARBON DIOXIDE BLOOD LEVEL; CELL MEMBRANE; CELL PH; CEREBROSPINAL FLUID; CONFUSION; DISEASE PREDISPOSITION; DISORDERS OF HIGHER CEREBRAL FUNCTION; DOWN REGULATION; DRUG ACCUMULATION; DRUG METABOLISM; ELECTROLYTE DISTURBANCE; ENDOCRINE FUNCTION; EXTRACELLULAR SPACE; HEART ARREST; HUMAN; HYPEROSMOLARITY; INFLAMMATION; KIDNEY DONOR; KIDNEY FUNCTION; LOCOMOTION; METABOLIC ACIDOSIS; NITROGEN METABOLISM; NONHUMAN; ORGAN INJURY; OSMOLALITY; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SODIUM URINE LEVEL; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; VASODILATATION; WATER CONTENT; WHITE MATTER; COMPLICATION; ELECTROLYTE BALANCE; METABOLISM; PATHOPHYSIOLOGY;

ACUTE KIDNEY INJURY; BLOOD-BRAIN BARRIER; BRAIN DEATH; BRAIN INJURIES; CONFUSION; HUMANS; INFLAMMATION; WATER-ELECTROLYTE BALANCE;

EID: 84902002914     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13907     Document Type: Review

References (81)

1. Li X, Hassoun HT, Santora R, Rabb H. Organ crosstalk: the role of the kidney. Curr Opin Crit Care 2009, 15:481-487. 10.1097/MCC.0b013e328332f69e, 19851101.
2. Yap SC, Lee HT. Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology 2012, 116:1139-1148. 10.1097/ALN.0b013e31824f951b, 22415388.
3. Grams ME, Rabb H. The distant organ effects of acute kidney injury. Kidney Int 2012, 81:942-948. 10.1038/ki.2011.241, 21814177.
4. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004, 107:1-16. 10.1016/j.clineuro.2004.07.012, 15567546.
5. Floerchinger B, Oberhuber R, Tullius SG. Effects of brain death on organ quality and transplant outcome. Transplant Rev (Orlando) 2012, 26:54-59. 10.1016/j.trre.2011.10.001, 22459036.
6. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995, 333:333-336. 10.1056/NEJM199508103330601, 7609748.
7. Khatri M, Himmelfarb J, Adams D, Becker K, Longstreth WT, Tirschwell DL. Acute kidney injury is associated with increased hospital mortality after stroke. J Stroke Cerebrovasc Dis 2014, 23:25-30. 10.1016/j.jstrokecerebrovasdis.2012.06.005, 22818389.
8. Davenport A. AKI in a patient with cirrhosis and ascites. Clin J Am Soc Nephrol 2012, 7:2041-2048. 10.2215/CJN.03390412, 22977213.
9. Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010, 25:1406-1416. 10.1093/ndt/gfq066, 20185818.
10. Palkovits M, Sebekova K, Gallatz K, Boor P, Sebekova K, Klassen A, Bahner U, Heidland A. Neuronal activation in the CNS during different forms of acute renal failure in rats. Neuroscience 2009, 159:862-882. 10.1016/j.neuroscience.2008.12.062, 19174183.
11. Yokoo H, Chiba S, Tomita K, Takashina M, Sagara H, Yagisita S, Takano Y, Hattori Y. Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone. PLoS One 2012, 7:e51539. 10.1371/journal.pone.0051539, 3517559, 23236515.
12. Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol 2001, 50:812-821.
13. Chastre A, Belanger M, Nguyen BN, Butterworth RF. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int 2013, doi:10.1111/liv.12252.
14. Butterworth RF. The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol 2013, 10:522-528. 10.1038/nrgastro.2013.99, 23817325.
15. Johnson HL, Jin F, Pirko I, Johnson AJ. Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption. J Neurovirol 2014, 20:107-112. 10.1007/s13365-013-0187-5, 23857332.
16. Lakhan SE, Kirchgessner A, Tepper D, Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol 2013, 4:32. 3615191, 23565108.
17. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008, 109:e102-e107. 10.1159/000142934, 2614446, 18802372.
18. Ratliff BB, Rabadi MM, Vasko R, Yasuda K, Goligorsky MS. Messengers without borders: mediators of systemic inflammatory response in AKI. J Am Soc Nephrol 2013, 24:529-536. 10.1681/ASN.2012060633, 23349311.
19. Andres-Hernando A, Dursun B, Altmann C, Ahuja N, He Z, Bhargava R, Edelstein CE, Jani A, Hoke TS, Klein C, Faubel S. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol Dial Transplant 2012, 27:4339-4347. 10.1093/ndt/gfs256, 3520082, 22778179.
20. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, Wu QQ, Hartono JR, Winterberg PD, Lu CY. Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 2011, 80:504-515. 10.1038/ki.2011.140, 3394593, 21633411.
21. Fuquay R, Renner B, Kulik L, McCullough JW, Amura C, Strassheim D, Pelanda R, Torres R, Thurman JM. Renal ischemia-reperfusion injury amplifies the humoral immune response. J Am Soc Nephrol 2013, 24:1063-1072. 10.1681/ASN.2012060560, 23641055.
22. Chi OZ, Hunter C, Liu X, Tan T, Weiss HR. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity. Pharmacology 2008, 82:187-192. 10.1159/000151433, 18708733.
23. Sadik NA, Mohamed WA, Ahmed MI. The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis. Mol Cell Biochem 2012, 359:73-81. 10.1007/s11010-011-1001-4, 21811803.
24. Salama M, Farrag SM, Abulasrar SA, Amin MM, Ali AA, Sheashaa H, Sobh M, Arias-Carrión O. Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol Disord Drug Targets 2013, 12:583-586. 10.2174/1871527311312050006, 23574173.
25. Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, Crow M, Ross CA, Mattson MP, Rabb H. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 2008, 19:1360-1370. 10.1681/ASN.2007080901, 2440297,2440297, 18385426.
26. Ali F, Tayeb O, Attallah A. Plasma and brain catecholamines in experimental uremia: acute and chronic studies. Life Sci 1985, 37:1757-1764. 10.1016/0024-3205(85)90217-6, 3932803.
27. O'Kane RL, Vina JR, Simpson I, Zaragoza R, Mokashi A, Hawkins RA. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab 2006, 291:E412-E419. 10.1152/ajpendo.00007.2006, 16569760.
28. Haase-Fielitz A, Haase M, Bellomo R, Lambert G, Matalanis G, Story D, Doolan L, Buxton B, Gutteridge G, Luft FC, Schunck WH, Dragun D. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009, 20:1393-1403. 10.1681/ASN.2008080915, 2689901, 19406978.
29. Adachi N, Lei B, Deshpande G, Seyfried FJ, Shimizu I, Nagaro T, Arai T. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats. Intensive Care Med 2001, 27:1655-1660. 10.1007/s001340101067, 11685308.
30. Jeppsson B, Freund HR, Gimmon Z, James JH, von Meyenfeldt MF, Fischer JE. Blood-brain barrier derangement in uremic encephalopathy. Surgery 1982, 92:30-35.
31. Daniel PM, Moorhouse SR, Pratt OE. Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain. Psychol Med 1976, 6:277-286. 10.1017/S0033291700013830, 12522.
32. Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014, 370:444-454. 10.1056/NEJMra1208705, 24476433.
33. Wei SG, Zhang ZH, Beltz TG, Yu Y, Johnson AK, Felder RB. Subfornical organ mediates sympathetic and haemodynamic responses to blood-borne proinflammatory cytokines. Hypertension 2013, 62:118-125. 10.1161/HYPERTENSIONAHA.113.01404, 23670302.
34. Skelly DT, Hennessy E, Dansereau MA, Cunningham C. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice. PLoS One 2013, 8:e69123. 10.1371/journal.pone.0069123, 3698075, 23840908.
35. Zaganas I, Pajecka K, Wendel Nielsen C, Schousboe A, Waagepetersen HS, Plaitakis A. The effect of pH and ADP on ammonia affinity for human glutamate dehydrogenases. Metab Brain Dis 2013, 28:127-131. 10.1007/s11011-013-9382-6, 23420347.
36. Rothman DL, De Feyter HM, Maciejewski PK, Behar KL. Is there in vivo evidence for amino acid shuttles carrying ammonia from neurons to astrocytes?. Neurochem Res 2012, 37:2597-2612. 10.1007/s11064-012-0898-7, 3702378, 23104556.
37. Zha XM. Acid-sensing ion channels: trafficking and synaptic function. Mol Brain 2013, doi:10.1186/1756-6606-6-1.
38. Samways DS, Harkins AB, Egan TM. Native and recombinant ASIC1a receptors conduct negligible Ca2+ entry. Cell Calcium 2009, 45:319-325. 10.1016/j.ceca.2008.12.002, 2890224, 19185346.
39. Zha XM, Costa V, Harding AM, Reznikov L, Benson CJ, Welsh MJ. ASIC2 subunits target acid-sensing ion channels to the synapse via an association with PSD-95. J Neurosci 2009, 29:8438-8446. 10.1523/JNEUROSCI.1284-09.2009, 2734339, 19571134.
40. Dabertrand F, Nelson MT, Brayden JE. Acidosis dilates brain parenchymal arterioles by conversion of calcium waves to sparks to activate BK channels. Circ Res 2012, 110:285-294. 10.1161/CIRCRESAHA.111.258145, 3505882, 22095728.
41. Vanholder R, Van Landschoot N, De Smet R, Schoots A, Ringoir S. Drug protein binding in chronic renal failure: evaluation of nine drugs. Kidney Int 1988, 33:996-1004. 10.1038/ki.1988.99, 3392889.
42. Arampatzis S, Funk GC, Leichtle AB, Fiedler GM, Schwarz C, Zimmermann H, Exadaktylos AK, Lindner G. Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis. BMC Med 2013, doi:10.1186/1741-7015-11-83.
43. Biasioli S, D'Andrea G, Feriani M, Chiaramonte S, Fabris A, Ronco C, La Greca G. Uremic encephalopathy: an updating. Clin Nephrol 1986, 25:57-63.
44. Davenport A, Jones SR, Goel S, Astley JP, Hartog M. Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin. Lancet 1993, 341:1614-1617. 10.1016/0140-6736(93)90757-8, 8099989.
45. Trachtman H, Futterweit S, Tonidandel W, Gullans SR. The role of organic osmolytes in the cerebral cell volume regulatory response to acute and chronic renal failure. J Am Soc Nephrol 1993, 3:1913-1919.
46. Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992, 3:12-27.
47. Silver SM. Cerebral edema after rapid dialysis is not caused by an increase in brain organic osmolytes. J Am Soc Nephrol 1995, 6:1600-1606.
48. Galons JP, Trouard T, Gmitro AF, Lien YH. Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging. J Clin Invest 1996, 98:750-755. 10.1172/JCI118847, 507485, 8698867.
49. Chen CL, Lai PH, Chou KJ, Lee PT, Chung HM, Fang HC. A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. Am J Neuroradiol 2007, 28:68-71.
50. Davenport A. Continuous renal replacement therapies in patients with acute neurological injury. Semin Dial 2009, 22:165-168. 10.1111/j.1525-139X.2008.00548.x, 19426422.
51. Hosoya K, Tachikawa M. Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins. Clin Exp Nephrol 2011, 15:478-485. 10.1007/s10157-011-0460-y, 21611756.
52. Mori S, Takanaga H, Ohtsuki S, Deguchi T, Kang YS, Hosoya K, Terasaki T. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 2003, 23:432-440.
53. Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 2004, 447:666-676. 10.1007/s00424-003-1089-9, 12883891.
54. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, European Uremic Toxin Work Group (EUTox) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943. 10.1046/j.1523-1755.2003.00924.x, 12675874, European Uremic Toxin Work Group (EUTox).
55. Enomoto A, Takeda M, Tojo A, Sekine T, Cha SH, Khamdang S, Takayama F, Aoyama I, Nakamura S, Endou H, Niwa T. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 2002, 13:1711-1720. 10.1097/01.ASN.0000022017.96399.B2, 12089366.
56. Deguchi T, Ohtsuki S, Otagiri M, Takanaga H, Asaba H, Mori S, Terasaki T. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 2002, 61:1760-1768. 10.1046/j.1523-1755.2002.00318.x, 11967025.
57. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 2007, 292:F1599-F1605. 10.1152/ajprenal.00473.2006, 17244891.
58. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, Terasaki T. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 2002, 83:57-66. 10.1046/j.1471-4159.2002.01108.x, 12358729.
59. Sun H, Frassetto L, Benet LZ. Effects of renal failure on drug transport and metabolism. Pharmacol Ther 2006, 109:1-11. 10.1016/j.pharmthera.2005.05.010, 16085315.
60. Vilay AM, Churchwell MD, Mueller BA. Clinical review: drug metabolism and nonrenal clearance in acute kidney injury. Crit Care 2008, 12:235. 10.1186/cc7093, 2646335, 19040780.
61. Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E. Is it cerebral or renal salt wasting?. Kidney Int 2009, 76:934-938. 10.1038/ki.2009.263, 19641485.
62. Sanchez-Fructuoso AI, Prats D, Marques M, Blanco J, Torrente J, Conesa J, Rio FD, Núñez JR, Barrientos A. Does donor brain death influence acute vascular rejection in the kidney transplant?. Transplantation 2004, 78:142-146.
63. Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation 2014, 97:258-264. 10.1097/01.TP.0000437178.48174.db, 24492420.
64. Herijgers P, Leunens V, Tjandra-Maga TB, Mubagwa K, Flameng W. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation 1996, 62:330-335. 10.1097/00007890-199608150-00005, 8779678.
65. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988, 45:32-36. 10.1097/00007890-198801000-00008, 3336918.
66. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998, 65:1533-1542. 10.1097/00007890-199806270-00001, 9665067.
67. Baan CC, Peeters AM, Demmers MW, Mol WM, Boer K, Samsom JN, Rowshani AT, Ijzermans JN, Weimar W. FoxP3 T cells and the pathophysiologic effects of brain death and warm ischemia in donor kidneys. Clin J Am Soc Nephrol 2012, 7:1481-1489. 10.2215/CJN.13041211, 3430949, 22745276.
68. Morariu AM, Schuurs TA, Leuvenink HG, van Oeveren W, Rakhorst G, Ploeg RJ. Early events in kidney donation: progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant 2008, 8:933-941. 10.1111/j.1600-6143.2008.02166.x, 18318776.
69. Li N, Zhao WG, Zhang WF. Acute kidney injury in patients with severe traumatic brain injury: implementation of the acute kidney injury network stage system. Neurocrit Care 2011, 14:377-381. 10.1007/s12028-011-9511-1, 21298359.
70. Fang L, You H, Chen B, Xu Z, Gao L, Liu J, Xie Q, Zhou Y, Gu Y, Lin S, Ding F. Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control study. Ren Fail 2010, 32:673-679. 10.3109/0886022X.2010.486492, 20540634.
71. Zacharia BE, Ducruet AF, Hickman ZL, Grobelny BT, Fernandez L, Schmidt JM, Narula R, Ko LN, Cohen ME, Mayer SA, Connolly ES. Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid haemorrhage: a single-center cohort study. Stroke 2009, 40:2375-2381. 10.1161/STROKEAHA.108.545210, 19461033.
72. Yanta J, Guyette FX, Doshi AA, Callaway CW, Rittenberger JC, Post Cardiac Arrest Service Renal dysfunction is common following resuscitation from out-of-hospital cardiac arrest. Resuscitation 2013, 84:1371-1374. 10.1016/j.resuscitation.2013.03.037, 23619738, Post Cardiac Arrest Service.
73. Rosen SM, O'Connor K, Shaldon S. Haemodialysis disequilibrium. Br Med J 1964, 2:672-675. 10.1136/bmj.2.5410.672, 1815765, 14171099.
74. Arieff AI, Massry SG, Barrientos A, Kleeman CR. Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 1973, 4:177-187. 10.1038/ki.1973.100, 4750910.
75. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 2001, 37:457-466. 10.1053/ajkd.2001.22068, 11228168.
76. Davenport A, Will EJ, Davison AM. Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. Contrib Nephrol 1991, 93:225-233.
77. Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure?. Kidney Int Suppl 1999, 72:S62-S66.
78. Vinsonneau C, Camus C, Combes A, de Costa Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF, Hemodiafe Study Group Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006, 368:379-385. 10.1016/S0140-6736(06)69111-3, 16876666, Hemodiafe Study Group.
79. Wu VC, Huang TM, Shiao CC, Lai CF, Tsai PR, Wang WJ, Huang HY, Wang KC, Ko WJ, Wu KD, NSARF Group The hemodynamic effects during sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for uremic patients with brain hemorrhage: a crossover study. J Neurosurg 2013, 119:1288-1295. 10.3171/2013.4.JNS122102, 23706048, NSARF Group.
80. Davenport A. Changing the hemodialysis prescription for hemodialysis patients with subdural and intracranial hemorrhage. Hemodial Int 2013, 17:S22-S27.
81. Sherlock M, O'Sullivan E, Agha A, Behan LA, Rawluk D, Brennan P, Tormey W, Thompson CJ. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2006, 64:250-254. 10.1111/j.1365-2265.2006.02432.x, 16487432.